709 filings
Page 9 of 36
4
0hvmgsejyxe24kh
25 May 22
KEMPHARM / Travis C Mickle ownership change
9:03pm
4
0cekmuk7 o8t32wauug
24 May 22
KEMPHARM / TAMARA A SEYMOUR ownership change
8:58pm
4
y6l82erzp39jvfst3gk
18 May 22
KEMPHARM / Matthew R Plooster ownership change
7:01pm
4
u8mikshpcda
18 May 22
KEMPHARM / Richard W Pascoe ownership change
5:25pm
4
m66 6y0r8d9j4
18 May 22
KEMPHARM / R. LaDuane Clifton ownership change
5:17pm
8-K
tkso9bt i7fnvx
16 May 22
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline
8:40am
DEFA14A
wpc267sv5 81w0ft
12 May 22
Additional proxy soliciting materials
5:26pm
8-K
dhb6iplwpib
12 May 22
KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates
4:48pm
8-K
sa5k1rucs2o137z
30 Mar 22
KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates
4:36pm
8-K
dykrpn4
21 Mar 22
KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
8:49am
8-K
subcpqf9hb8xw
16 Mar 22
KemPharm team provided development and regulatory services to Corium pursuant to a master development services agreement
8:32am
8-K
1jnkxrl nlmiyb6km
22 Feb 22
Regulation FD Disclosure
9:09am
SC 13G
8vjoy0y94gndg4
4 Feb 22
KEMPHARM / BlackRock ownership change
4:12pm
4
zra4hvz
3 Feb 22
KEMPHARM / Timothy J. Sangiovanni ownership change
5:17pm
4
lsphyy i02
3 Feb 22
KEMPHARM / Sven Guenther ownership change
5:17pm
4
p1myall2 6n
3 Feb 22
KEMPHARM / R. LaDuane Clifton ownership change
5:15pm
4
bbasr2wn8w1e b5l
3 Feb 22
KEMPHARM / Richard W Pascoe ownership change
5:14pm